Insider · CIK 0001229245
Jennifer L Good
Files at TRVI (Trevi Therapeutics, Inc.), RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Mar 25, 2025, latest Mar 25, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TRVI: Trevi Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | TRVIsell Trevi Therapeutics, Inc. | $35k 5,263 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Stock Option (right to buy)derivative | +7,037 | $0.00 | $0 | 7,037 | Jun 26, 2025 |
| Jun 24, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +4,712 | $0.00 | $0 | 4,712 | Jun 26, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +4,000 | - | - | 7,000 | Jun 23, 2025 |
| Jun 18, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
| May 31, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Performance Stock Option (right to buy)derivative | +102,000 | $0.00 | $0 | 156,400 | Jun 3, 2025 |
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | MOption exercise Common Stock | +5,263 | $1.43 | $7,526 | 218,576 | Mar 25, 2025 |
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | SOpen-market sale Common Stock | -5,263 | $6.58 | $35k | 213,313 | Mar 25, 2025 |
| Mar 21, 2025 | TRVI Trevi Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -5,263 | $0.00 | $0 | 0 | Mar 25, 2025 |
| Mar 10, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Performance Stock Option (right to buy)derivative | +54,400 | $0.00 | $0 | 54,400 | Mar 12, 2025 |
| Feb 18, 2025 | TRVI Trevi Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +811,000 | $0.00 | $0 | 811,000 | Feb 20, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.